Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure BNT Q4 2024 Earnings Slight Profit Amid Quiet Quarter COTY Q1 2026 Earnings EPS Misses Estimates Significantly Revenue Details Unavailable STRS Q3 2023 Earnings Loss Reported Amidst Limited Revenue Visibility CACC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Subprime Auto Lending Landscape SOFI Q1 2026 Earnings EPS Slightly Below Estimates Stock Dips Marginally